Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Survival of inflammatory breast cancer patients compared to non-inflammatory breast cancer patients in Egypt.

Spencer B, Banerjee M, Omar S, Khaled H, Anwar N, Zaghloul MS, Eissa S, Kleer CG, Dey S, Merajver SD, Soliman AS.

Breast J. 2011 Sep-Oct;17(5):545-7. doi: 10.1111/j.1524-4741.2011.01146.x. Epub 2011 Aug 9. No abstract available.

PMID:
21827567
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Identifying factors that impact survival among women with inflammatory breast cancer.

Dawood S, Ueno NT, Valero V, Woodward WA, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM, Cristofanilli M.

Ann Oncol. 2012 Apr;23(4):870-5. doi: 10.1093/annonc/mdr319. Epub 2011 Jul 15.

PMID:
21765048
[PubMed - indexed for MEDLINE]
Free Article
3.

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort.

Gianni L, Eiermann W, Semiglazov V, Lluch A, Tjulandin S, Zambetti M, Moliterni A, Vazquez F, Byakhov MJ, Lichinitser M, Climent MA, Ciruelos E, Ojeda B, Mansutti M, Bozhok A, Magazzù D, Heinzmann D, Steinseifer J, Valagussa P, Baselga J.

Lancet Oncol. 2014 May;15(6):640-7. doi: 10.1016/S1470-2045(14)70080-4. Epub 2014 Mar 20.

PMID:
24657003
[PubMed - indexed for MEDLINE]
4.

Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database.

Rueth NM, Lin HY, Bedrosian I, Shaitelman SF, Ueno NT, Shen Y, Babiera G.

J Clin Oncol. 2014 Jul 1;32(19):2018-24. doi: 10.1200/JCO.2014.55.1978. Epub 2014 Jun 2.

PMID:
24888808
[PubMed - indexed for MEDLINE]
5.

Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.

Lacerda L, Reddy JP, Liu D, Larson R, Li L, Masuda H, Brewer T, Debeb BG, Xu W, Hortobágyi GN, Buchholz TA, Ueno NT, Woodward WA.

Stem Cells Transl Med. 2014 Jul;3(7):849-56. doi: 10.5966/sctm.2013-0204. Epub 2014 May 15.

PMID:
24833589
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences.

Oven Ustaalioglu BB, Bilici A, Kefeli U, Seker M, Yildirim E, Salepci T, Oncel M, Kement M, Gumus M.

Oncology. 2010;79(1-2):105-11. doi: 10.1159/000320162. Epub 2010 Nov 22.

PMID:
21088436
[PubMed - indexed for MEDLINE]
7.

Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases.

Veronesi U, Galimberti V, Paganelli G, Maisonneuve P, Viale G, Orecchia R, Luini A, Intra M, Veronesi P, Caldarella P, Renne G, Rotmensz N, Sangalli C, De Brito Lima L, Tullii M, Zurrida S.

Eur J Cancer. 2009 May;45(8):1381-8. doi: 10.1016/j.ejca.2008.11.041. Epub 2009 Jan 6.

PMID:
19128957
[PubMed - indexed for MEDLINE]
8.

Does age predict outcome in patients with inflammatory breast cancer?

Ahmed S, Lawrence J, Stewart JH, Melin S, Levine EA, Howard-McNatt M.

Am Surg. 2014 Aug;80(8):E221-4. No abstract available.

PMID:
25105373
[PubMed - indexed for MEDLINE]
9.

Survival of women with inflammatory breast cancer: a large population-based study.

Dawood S, Lei X, Dent R, Gupta S, Sirohi B, Cortes J, Cristofanilli M, Buchholz T, Gonzalez-Angulo AM.

Ann Oncol. 2014 Jun;25(6):1143-51. doi: 10.1093/annonc/mdu121. Epub 2014 Mar 24.

PMID:
24669011
[PubMed - indexed for MEDLINE]
10.

p53 protein accumulation and presence of visceral metastasis are independent prognostic factors for survival in patients with metastatic inflammatory breast carcinoma.

Sezgin C, Gokmen E, Kapkac M, Zekioglu O, Esassolak M, Karabulut B, Sanli UA, Uslu R.

Med Princ Pract. 2011;20(2):159-64. doi: 10.1159/000319916. Epub 2011 Jan 20.

PMID:
21252573
[PubMed - indexed for MEDLINE]
11.

Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.

Schlichting JA, Soliman AS, Schairer C, Schottenfeld D, Merajver SD.

Breast Cancer Res Treat. 2012 Aug;134(3):1257-68. doi: 10.1007/s10549-012-2133-2. Epub 2012 Jun 26.

PMID:
22733221
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Inflammatory breast cancer: the road to progress.

Chung CT, Martino S.

Oncology (Williston Park). 2011 Mar;25(3):280, 282. Review. No abstract available.

PMID:
21548472
[PubMed - indexed for MEDLINE]
Free Article
13.

Have we made progress in inflammatory breast cancer? Not so fast.

Hunt KK, Woodward WA.

Oncology (Williston Park). 2011 Mar;25(3):276, 278. Review. No abstract available.

PMID:
21548471
[PubMed - indexed for MEDLINE]
Free Article
14.

Modern outcomes of inflammatory breast cancer.

Rehman S, Reddy CA, Tendulkar RD.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):619-24. doi: 10.1016/j.ijrobp.2012.01.030. Epub 2012 Mar 22.

PMID:
22445003
[PubMed - indexed for MEDLINE]
15.

Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.

Dawood S, Ueno NT, Valero V, Woodward WA, Buchholz TA, Hortobagyi GN, Gonzalez-Angulo AM, Cristofanilli M.

Cancer. 2011 May 1;117(9):1819-26. doi: 10.1002/cncr.25682. Epub 2010 Nov 29.

PMID:
21509759
[PubMed - indexed for MEDLINE]
Free Article
16.

Resection of liver metastases in patients with breast cancer: survival and prognostic factors.

van Walsum GA, de Ridder JA, Verhoef C, Bosscha K, van Gulik TM, Hesselink EJ, Ruers TJ, van den Tol MP, Nagtegaal ID, Brouwers M, van Hillegersberg R, Porte RJ, Rijken AM, Strobbe LJ, de Wilt JH; Dutch Liver Surgeons Group.

Eur J Surg Oncol. 2012 Oct;38(10):910-7. doi: 10.1016/j.ejso.2012.04.015. Epub 2012 Jun 7.

PMID:
22682709
[PubMed - indexed for MEDLINE]
17.

Breast cancer subtypes can be a predictor of pathologic complete response and survival in the neoadjuvant setting for T4 noninflammatory breast cancer.

Gülben K, Berberoğlu U, Kinaş V, Başkan E.

Acta Chir Belg. 2014 May-Jun;114(3):153-9.

PMID:
25102703
[PubMed - indexed for MEDLINE]
18.

Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer.

Adkins D, Brown R, Trinkaus K, Maziarz R, Luedke S, Freytes C, Needles B, Wienski D, Fracasso P, Pluard T, Moriconi W, Ryan T, Hoelzer K, Safdar S, Rearden T, Rodriguez G, Khoury H, Vij R, DiPersio J.

J Clin Oncol. 1999 Jul;17(7):2006-14.

PMID:
10561251
[PubMed - indexed for MEDLINE]
19.

Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.

Shenouda MN, Sadek BT, Goldberg SI, Keruakous AR, Croft BJ, Abi Raad RF, Taghian AG.

Clin Breast Cancer. 2014 Jun;14(3):198-204. doi: 10.1016/j.clbc.2013.12.007. Epub 2013 Dec 27.

PMID:
24485702
[PubMed - indexed for MEDLINE]
20.

Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.

Kim HJ, Im SA, Keam B, Kim YJ, Han SW, Kim TM, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Noh DY, Heo DS, Park IA, Bang YJ, Ha SW.

J Neurooncol. 2012 Jan;106(2):303-13. doi: 10.1007/s11060-011-0664-8. Epub 2011 Sep 22.

PMID:
21938531
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk